FDA Eyes Suicide Links With Merck's Singulair
Federal regulators are investigating Merck & Co. Inc.'s Singulair amid reports linking the blockbuster asthma drug to mood changes and suicidal behavior in consumers, the U.S. Food and Drug Administration announced...To view the full article, register now.
Already a subscriber? Click here to view full article